MS in Motion - a Column by Mike Knight

Going All In for Ocrevus ā€” Together

ā€œIs the MS drug news good for u?ā€ my friendā€™s text asked. It was Wednesday morning, March 29. Genentech had just announcedĀ  that Ocrevus, the ā€œFirst and only approved disease-modifying therapy for primary progressive form of multiple sclerosis (PPMS) ā€“ one of the most disabling forms of…